Delivery Order SPE2DB20D9127-SPE2DB25FPPS7

Award Date 1/28/25
Potential Completion Date 1/29/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $5,678.70 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Nucala 100 mg/ml auto-injectors. This delivery order is part of a larger single-award indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC covers a comprehensive range of pharmaceutical items to fulfill the recurring...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,357.40, is for the procurement of Nucala 100 mg/mL auto-injectors to support the medical supply needs of military healthcare facilities. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA,...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $3,785.80 to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the supply of 100 mg/mL Nucala auto-injectors, a prescription medication used to treat severe asthma. This delivery order is part of a larger single-award indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with DLA for the provision of a wide range of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,357.40, is for the delivery of Nucala 100 mg/mL auto-injectors to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,357.40 firm fixed-price contract is for the delivery of Nucala 100 mg/mL auto-injectors to support the medical supply needs of military health facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows...
The U.S. Defense Logistics Agency (DLA) awarded a $11,357.40 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Nucala 100 mg/mL auto-injectors to support the recurring medical supply needs of military health facilities worldwide. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,892.90 contract is for the delivery of Nucala 100 mg/mL auto-injectors. This delivery order falls under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to military healthcare facilities. The...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $7,571.60 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Nucala 100 mg/mL auto-injectors to support the recurring medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,892.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and DLA, valued up to $499,999,999, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $17,036.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order falls under a larger single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which covers a wide range of pharmaceutical products and medical supplies to support the...
  • SPE2DB20D9127
    Indefinite Delivery Contract
  • SPE2DB20D9127-SPE2DB25FPPS7
    Delivery Order

The Defense Logistics Agency (DLA) awarded a $11,357.40 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the procurement of Nucala 100 mg/mL auto-injectors. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across multiple pharmaceutical product categories.

Generated 4/29/25, 9:43 AM